ArticleJournal of clinical medicine2021

Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study.

Davide Giuseppe Ribaldone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.